Director Dianne M Parrotte sold 44,000 shares of CGNX at $54.00 for $2.4M on 2026-03-02, reducing holdings by 56.8%.
Dianne M Parrotte executed four separate sales totaling 44,000 shares for $2,376,000.00 at $54.00 per share on 2026-03-02, reducing her stake from 77,431 shares to 33,431 shares—a reduction of 56.8% of her pre-transaction holdings. The blended transaction price of $54.00 is 0.73% above the current price of $53.61 and sits 8.8% below the 52-week high of $58.79, placing the sale within the upper portion of the stock's recent trading range despite a strong 30-day (+38.4%) and 90-day (+42.2%) price run-up. Her cross-ticker track record shows 1 prior buy with an average 90-day return of +3.2% and a 100% win rate, though that specific trade at CGNX on 2024-08-07 followed a pattern where the stock rose after her buy. This large, multi-tranche liquidation represents a material reduction in director-level ownership and warrants monitoring of subsequent filings to assess whether it reflects a one-time capital event or a broader shift in her conviction in the company.
Director Parrotte buys 2,000 shares of CGNX at $38.62; stock down -26.8% from 52-week high amid -16.8% annual revenue decline.
Director Dianne M Parrotte purchased 2,000 shares at $38.62, increasing her holdings from 9,340 to 11,340 shares. The purchase occurs in a context of material stock weakness: the current price of $38.75 is -26.8% from the 52-week high of $52.91, and the stock has declined -20.0% over the prior 30 days. Cognex's fundamentals show strain, with annual revenue down -16.8% year-over-year despite a market cap of $6.6B and a notably elevated P/E of 84.24, suggesting elevated valuation relative to current earnings. This is a discretionary open-market purchase by a director during a period of significant stock decline and deteriorating top-line growth.
